Mod-GRF (1-29): Dosage, Protocol, and Research Guide

CJC-1295 without DAC for pulsatile GH release

Mechanism

Short-acting GHRH analog that amplifies natural GH pulses when combined with GHRPs

Protocol at a glance

Starting dose100mcg
Maintenance dose100mcg
Maximum dose200mcg
Frequency2-3x daily
Typical duration8-12 weeks
RouteSubcutaneous
Injection siteAbdomen
TimingEmpty stomach, with GHRP

Side effects

Contraindications

Protocol notes

Frequently asked questions

What is Mod-GRF (1-29) and how does it work?

Mod-GRF (1-29) is a short-acting GHRH (growth hormone-releasing hormone) analog, also known as CJC-1295 without DAC. It functions as a pulsatile growth hormone releaser, meaning it amplifies the body's natural GH pulses rather than maintaining constant hormone elevation. Unlike its DAC counterpart, Mod-GRF (1-29) has a 30-minute half-life, which preserves the natural GH rhythm and allows for multiple distinct pulses throughout the day when dosed 2-3 times daily.

What is the correct dosing protocol for Mod-GRF (1-29)?

The standard protocol for Mod-GRF (1-29) begins at a starting dose of 100 micrograms (mcg) per injection. The maintenance dose is 100 mcg, and the maximum recommended dose is 200 mcg. Administration frequency is 2-3 times daily via subcutaneous injection into the abdomen. The typical research protocol duration is 8-12 weeks, followed by a break to assess outcomes and allow the body to reset before potential future cycles.

What are the side effects of Mod-GRF (1-29)?

Common side effects of Mod-GRF (1-29) include flushing, a head rush sensation, and mild hypoglycemia. These effects are typically transient and often diminish as the body adapts to the peptide. Most researchers report that side effects are manageable and short-lived. However, if persistent or severe reactions occur, consult with a healthcare provider.

How should Mod-GRF (1-29) be administered?

Mod-GRF (1-29) is administered via subcutaneous injection into the abdomen. Proper timing is crucial: injections should be taken on an empty stomach, ideally in combination with a GHRP (growth hormone-releasing peptide). The empty stomach requirement ensures optimal absorption and effectiveness. The 30-minute half-life means that multiple daily doses (2-3) create distinct GH pulses, maximizing the effectiveness of the protocol.

Should I stack Mod-GRF (1-29) with other peptides?

Mod-GRF (1-29) is designed to be combined with GHRPs (growth hormone-releasing peptides). This combination creates a synergistic effect, as the two peptides work on different receptor pathways to amplify GH pulse amplitude and frequency. The combination is considered the best approach for maximizing research outcomes. When using Mod-GRF (1-29), timing the GHRP administration alongside the injection on an empty stomach is critical for optimal results.

How long should I cycle Mod-GRF (1-29)?

The recommended cycle duration for Mod-GRF (1-29) is 8-12 weeks. This timeframe allows sufficient research time to assess the effects of the peptide on growth hormone dynamics. After completing an 8-12 week cycle, it is advisable to take a break before considering another research protocol. This cycling approach helps maintain the body's responsiveness and reduces the risk of tolerance development.

Who should not use Mod-GRF (1-29)?

Mod-GRF (1-29) has specific contraindications that must be respected. The peptide should not be used by individuals with active cancer or diabetic retinopathy. Additionally, for research purposes only — not FDA-approved for human use. Consult a licensed physician before use. Anyone with pre-existing medical conditions, taking medications, or with concerns about suitability should consult with a healthcare provider before beginning any research protocol involving Mod-GRF (1-29).

More Growth Hormone Peptides peptides · All peptide guides · Free dose calculator

Educational reference only — not medical advice. Work with a qualified clinician.

Loading Alethea Health...